Testing effectiveness (Phase 2)Study completedNCT01536431
What this trial is testing
Safety Study to Assess Whether Proinsulin Peptide Injections Can Slow or Stop the Body Damaging Its Own Insulin-making Cells in the Pancreas in Patients Newly Diagnosed With Type 1 Diabetes
Who this might be right for
Type 1 Diabetes
Cardiff University 27